+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Antipyrine Market by Product Type, Application, End User, Distribution Channel, Age Group, Therapeutic Class - Global Forecast 2025-2030- Product Image
Antipyrine Market by Product Type, Application, End User, Distribution Channel, Age Group, Therapeutic Class - Global Forecast 2025-2030- Product Image
Sale

Antipyrine Market by Product Type, Application, End User, Distribution Channel, Age Group, Therapeutic Class - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 189 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 6013887
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Antipyrine Market grew from USD 363.22 million in 2023 to USD 382.99 million in 2024. It is expected to continue growing at a CAGR of 4.34%, reaching USD 489.29 million by 2030.

Antipyrine, a pharmaceutical drug primarily used for its analgesic and antipyretic properties, finds its relevance in both human and veterinary medicine. Its scope is defined by its application in treating mild pain and fever, and it serves as a key ingredient in prescribed ear solutions for addressing ear pain and inflammation. The necessity of antipyrine is evident in its therapeutic efficacy, especially for patients requiring non-opioid pain management solutions. The application spans across medical professionals and healthcare providers who administer antipyrine-based solutions, while the end-use scope includes hospitals, clinics, and veterinary centers. Key growth influencers in the antipyrine market encompass rising demands for non-prescription medications in pain management and increasing prevalence of ear-related disorders, which are bolstered by the expansion of healthcare infrastructure globally. The latest opportunities are noticeable in emerging markets with growing access to healthcare services and increasing awareness about non-opioid alternatives. Companies can capitalize on these by focusing on strategic partnerships and expanding production capabilities to cope with heightened demand. However, market limitations stem from regulatory challenges, potential side effects associated with over-the-counter use, and competitive pressures from alternative pain relief medications that are gaining popularity. Pharmacological R&D and innovations tailored to enhance delivery mechanisms and efficacy could carve new pathways for antipyrine derivatives, particularly in personalized medicine. Furthermore, conducting extensive clinical studies and expanding awareness through educational initiatives could mitigate constraints. The nature of the antipyrine market is competitive yet promising, driven by an increase in healthcare spending and consumer inclination towards effective and affordable over-the-counter solutions. In conclusion, a blend of expansion in emerging markets, innovation in drug formulation, and overcoming regulatory hurdles offer the most promising avenues for business growth and market penetration in this field.

Understanding Market Dynamics in the Antipyrine Market

The Antipyrine Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Expansion of research activities focusing on the anti-inflammatory properties of antipyrine
    • Escalating demand for over-the-counter antipyrine medications influencing market dynamics
    • Enhanced focus on developing combination therapies featuring antipyrine for better clinical outcomes
    • Government initiatives and funding for the development of generic antipyrine medications boosting market growth
  • Market Restraints
    • The increasing scrutiny and public awareness of the potential side effects and safety concerns associated with antipyrine, impacting consumer trust and sales
    • The challenges in sourcing and ensuring the consistent supply of high-quality raw materials required for manufacturing antipyrine, which can affect production efficiency
  • Market Opportunities
    • Increased demand for antipyrine in pharmaceutical formulations driven by rising healthcare investments
    • Expansion of antipyrine applications in veterinary medicines due to rising pet adoption rates
    • Growing need for antipyrine in pain management solutions spurred by aging population trends
  • Market Challenges
    • Managing supply chain disruptions and raw material price volatility in the antipyrine industry
    • Implementing cutting-edge technological advancements and innovation in the antipyrine production process

Exploring Porter’s Five Forces for the Antipyrine Market

Porter’s Five Forces framework further strengthens the insights of the Antipyrine Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Antipyrine Market

External macro-environmental factors deeply influence the performance of the Antipyrine Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Antipyrine Market

The Antipyrine Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Antipyrine Market

The Antipyrine Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Antipyrine Market

The Antipyrine Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Antipyrine Market, highlighting leading vendors and their innovative profiles. These include AbbVie, Amgen, AstraZeneca, Bayer, Bristol-Myers Squibb, Eli Lilly and Company, Gilead Sciences, GlaxoSmithKline, Hoffmann-La Roche, Johnson & Johnson, Merck & Co., Novartis, Novo Nordisk, Pfizer, Roche, Sanofi, Shionogi, Sun Pharmaceutical, Takeda Pharmaceutical Company, and Teva Pharmaceutical Industries.

Market Segmentation & Coverage

This research report categorizes the Antipyrine Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Product Type
    • Capsules
    • Injectable
    • Liquid
    • Powder
    • Tablets
  • Application
    • Anti-Inflammatory
    • Arthritis
    • Cold and Flu
    • Fever Reduction
    • Pain Relief
  • End User
    • Clinics
    • Homecare
    • Hospitals
    • Research Institutes
  • Distribution Channel
    • Drug Stores
    • Hospital Pharmacies
    • Online Pharmacies
    • Retail Pharmacies
  • Age Group
    • Adults
    • Geriatrics
    • Pediatrics
  • Therapeutic Class
    • Analgesics
    • Antipyretics
    • NSAIDs
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Expansion of research activities focusing on the anti-inflammatory properties of antipyrine
5.1.1.2. Escalating demand for over-the-counter antipyrine medications influencing market dynamics
5.1.1.3. Enhanced focus on developing combination therapies featuring antipyrine for better clinical outcomes
5.1.1.4. Government initiatives and funding for the development of generic antipyrine medications boosting market growth
5.1.2. Restraints
5.1.2.1. The increasing scrutiny and public awareness of the potential side effects and safety concerns associated with antipyrine, impacting consumer trust and sales
5.1.2.2. The challenges in sourcing and ensuring the consistent supply of high-quality raw materials required for manufacturing antipyrine, which can affect production efficiency
5.1.3. Opportunities
5.1.3.1. Increased demand for antipyrine in pharmaceutical formulations driven by rising healthcare investments
5.1.3.2. Expansion of antipyrine applications in veterinary medicines due to rising pet adoption rates
5.1.3.3. Growing need for antipyrine in pain management solutions spurred by aging population trends
5.1.4. Challenges
5.1.4.1. Managing supply chain disruptions and raw material price volatility in the antipyrine industry
5.1.4.2. Implementing cutting-edge technological advancements and innovation in the antipyrine production process
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Antipyrine Market, by Product Type
6.1. Introduction
6.2. Capsules
6.3. Injectable
6.4. Liquid
6.5. Powder
6.6. Tablets
7. Antipyrine Market, by Application
7.1. Introduction
7.2. Anti-Inflammatory
7.3. Arthritis
7.4. Cold and Flu
7.5. Fever Reduction
7.6. Pain Relief
8. Antipyrine Market, by End User
8.1. Introduction
8.2. Clinics
8.3. Homecare
8.4. Hospitals
8.5. Research Institutes
9. Antipyrine Market, by Distribution Channel
9.1. Introduction
9.2. Drug Stores
9.3. Hospital Pharmacies
9.4. Online Pharmacies
9.5. Retail Pharmacies
10. Antipyrine Market, by Age Group
10.1. Introduction
10.2. Adults
10.3. Geriatrics
10.4. Pediatrics
11. Antipyrine Market, by Therapeutic Class
11.1. Introduction
11.2. Analgesics
11.3. Antipyretics
11.4. NSAIDs
12. Americas Antipyrine Market
12.1. Introduction
12.2. Argentina
12.3. Brazil
12.4. Canada
12.5. Mexico
12.6. United States
13. Asia-Pacific Antipyrine Market
13.1. Introduction
13.2. Australia
13.3. China
13.4. India
13.5. Indonesia
13.6. Japan
13.7. Malaysia
13.8. Philippines
13.9. Singapore
13.10. South Korea
13.11. Taiwan
13.12. Thailand
13.13. Vietnam
14. Europe, Middle East & Africa Antipyrine Market
14.1. Introduction
14.2. Denmark
14.3. Egypt
14.4. Finland
14.5. France
14.6. Germany
14.7. Israel
14.8. Italy
14.9. Netherlands
14.10. Nigeria
14.11. Norway
14.12. Poland
14.13. Qatar
14.14. Russia
14.15. Saudi Arabia
14.16. South Africa
14.17. Spain
14.18. Sweden
14.19. Switzerland
14.20. Turkey
14.21. United Arab Emirates
14.22. United Kingdom
15. Competitive Landscape
15.1. Market Share Analysis, 2023
15.2. FPNV Positioning Matrix, 2023
15.3. Competitive Scenario Analysis
15.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. ANTIPYRINE MARKET RESEARCH PROCESS
FIGURE 2. ANTIPYRINE MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL ANTIPYRINE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL ANTIPYRINE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL ANTIPYRINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
FIGURE 7. GLOBAL ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL ANTIPYRINE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 9. GLOBAL ANTIPYRINE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL ANTIPYRINE MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 11. GLOBAL ANTIPYRINE MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
FIGURE 13. GLOBAL ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2023 VS 2030 (%)
FIGURE 15. GLOBAL ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. GLOBAL ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2023 VS 2030 (%)
FIGURE 17. GLOBAL ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. AMERICAS ANTIPYRINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. AMERICAS ANTIPYRINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. UNITED STATES ANTIPYRINE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 21. UNITED STATES ANTIPYRINE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. ASIA-PACIFIC ANTIPYRINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 23. ASIA-PACIFIC ANTIPYRINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA ANTIPYRINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 25. EUROPE, MIDDLE EAST & AFRICA ANTIPYRINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 26. ANTIPYRINE MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 27. ANTIPYRINE MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. ANTIPYRINE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL ANTIPYRINE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL ANTIPYRINE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL ANTIPYRINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. ANTIPYRINE MARKET DYNAMICS
TABLE 7. GLOBAL ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL ANTIPYRINE MARKET SIZE, BY CAPSULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL ANTIPYRINE MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL ANTIPYRINE MARKET SIZE, BY LIQUID, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL ANTIPYRINE MARKET SIZE, BY POWDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL ANTIPYRINE MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL ANTIPYRINE MARKET SIZE, BY ANTI-INFLAMMATORY, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL ANTIPYRINE MARKET SIZE, BY ARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL ANTIPYRINE MARKET SIZE, BY COLD AND FLU, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL ANTIPYRINE MARKET SIZE, BY FEVER REDUCTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL ANTIPYRINE MARKET SIZE, BY PAIN RELIEF, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL ANTIPYRINE MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL ANTIPYRINE MARKET SIZE, BY HOMECARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL ANTIPYRINE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL ANTIPYRINE MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL ANTIPYRINE MARKET SIZE, BY DRUG STORES, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL ANTIPYRINE MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL ANTIPYRINE MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL ANTIPYRINE MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL ANTIPYRINE MARKET SIZE, BY ADULTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL ANTIPYRINE MARKET SIZE, BY GERIATRICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL ANTIPYRINE MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL ANTIPYRINE MARKET SIZE, BY ANALGESICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL ANTIPYRINE MARKET SIZE, BY ANTIPYRETICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL ANTIPYRINE MARKET SIZE, BY NSAIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS ANTIPYRINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 44. ARGENTINA ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 45. ARGENTINA ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 46. ARGENTINA ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 47. ARGENTINA ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 48. ARGENTINA ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 49. ARGENTINA ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 50. BRAZIL ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 51. BRAZIL ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 52. BRAZIL ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 53. BRAZIL ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 54. BRAZIL ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 55. BRAZIL ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 56. CANADA ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 57. CANADA ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 58. CANADA ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 59. CANADA ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 60. CANADA ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 61. CANADA ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 62. MEXICO ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 63. MEXICO ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 64. MEXICO ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 65. MEXICO ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 66. MEXICO ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 67. MEXICO ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES ANTIPYRINE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 75. ASIA-PACIFIC ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 76. ASIA-PACIFIC ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 77. ASIA-PACIFIC ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 78. ASIA-PACIFIC ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 79. ASIA-PACIFIC ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 80. ASIA-PACIFIC ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 81. ASIA-PACIFIC ANTIPYRINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 82. AUSTRALIA ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 83. AUSTRALIA ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 84. AUSTRALIA ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 85. AUSTRALIA ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 86. AUSTRALIA ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 87. AUSTRALIA ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 88. CHINA ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 89. CHINA ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 90. CHINA ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 91. CHINA ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 92. CHINA ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 93. CHINA ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 94. INDIA ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 95. INDIA ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 96. INDIA ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 97. INDIA ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 98. INDIA ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 99. INDIA ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 100. INDONESIA ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 101. INDONESIA ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 102. INDONESIA ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 103. INDONESIA ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 104. INDONESIA ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 105. INDONESIA ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 106. JAPAN ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 107. JAPAN ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 108. JAPAN ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 109. JAPAN ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 110. JAPAN ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 111. JAPAN ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 112. MALAYSIA ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 113. MALAYSIA ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 114. MALAYSIA ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 115. MALAYSIA ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 116. MALAYSIA ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 117. MALAYSIA ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 118. PHILIPPINES ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 119. PHILIPPINES ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 120. PHILIPPINES ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 121. PHILIPPINES ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 122. PHILIPPINES ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 123. PHILIPPINES ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 124. SINGAPORE ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 125. SINGAPORE ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 126. SINGAPORE ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 127. SINGAPORE ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 128. SINGAPORE ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 129. SINGAPORE ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 130. SOUTH KOREA ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 131. SOUTH KOREA ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 132. SOUTH KOREA ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 133. SOUTH KOREA ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 134. SOUTH KOREA ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 135. SOUTH KOREA ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 136. TAIWAN ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 137. TAIWAN ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 138. TAIWAN ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 139. TAIWAN ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 140. TAIWAN ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 141. TAIWAN ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 142. THAILAND ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 143. THAILAND ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 144. THAILAND ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 145. THAILAND ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 146. THAILAND ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 147. THAILAND ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 148. VIETNAM ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 149. VIETNAM ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 150. VIETNAM ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 151. VIETNAM ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 152. VIETNAM ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 153. VIETNAM ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA ANTIPYRINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 161. DENMARK ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 162. DENMARK ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 163. DENMARK ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 164. DENMARK ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 165. DENMARK ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 166. DENMARK ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 167. EGYPT ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 168. EGYPT ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 169. EGYPT ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 170. EGYPT ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 171. EGYPT ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 172. EGYPT ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 173. FINLAND ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 174. FINLAND ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 175. FINLAND ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 176. FINLAND ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 177. FINLAND ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 178. FINLAND ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 179. FRANCE ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 180. FRANCE ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 181. FRANCE ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 182. FRANCE ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 183. FRANCE ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 184. FRANCE ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 185. GERMANY ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 186. GERMANY ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 187. GERMANY ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 188. GERMANY ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 189. GERMANY ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 190. GERMANY ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 191. ISRAEL ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 192. ISRAEL ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 193. ISRAEL ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 194. ISRAEL ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 195. ISRAEL ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 196. ISRAEL ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 197. ITALY ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 198. ITALY ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 199. ITALY ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 200. ITALY ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 201. ITALY ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 202. ITALY ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 203. NETHERLANDS ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 204. NETHERLANDS ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 205. NETHERLANDS ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 206. NETHERLANDS ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 207. NETHERLANDS ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 208. NETHERLANDS ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 209. NIGERIA ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 210. NIGERIA ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 211. NIGERIA ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 212. NIGERIA ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 213. NIGERIA ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 214. NIGERIA ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 215. NORWAY ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 216. NORWAY ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 217. NORWAY ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 218. NORWAY ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 219. NORWAY ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 220. NORWAY ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 221. POLAND ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 222. POLAND ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 223. POLAND ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 224. POLAND ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 225. POLAND ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 226. POLAND ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 227. QATAR ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 228. QATAR ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 229. QATAR ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 230. QATAR ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 231. QATAR ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 232. QATAR ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 233. RUSSIA ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 234. RUSSIA ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 235. RUSSIA ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 236. RUSSIA ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 237. RUSSIA ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 238. RUSSIA ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 239. SAUDI ARABIA ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 240. SAUDI ARABIA ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 241. SAUDI ARABIA ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 242. SAUDI ARABIA ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 243. SAUDI ARABIA ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 244. SAUDI ARABIA ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 245. SOUTH AFRICA ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 246. SOUTH AFRICA ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 247. SOUTH AFRICA ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 248. SOUTH AFRICA ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 249. SOUTH AFRICA ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 250. SOUTH AFRICA ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 251. SPAIN ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 252. SPAIN ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 253. SPAIN ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 254. SPAIN ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 255. SPAIN ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 256. SPAIN ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 257. SWEDEN ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 258. SWEDEN ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 259. SWEDEN ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 260. SWEDEN ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 261. SWEDEN ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 262. SWEDEN ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 263. SWITZERLAND ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 264. SWITZERLAND ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 265. SWITZERLAND ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 266. SWITZERLAND ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 267. SWITZERLAND ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 268. SWITZERLAND ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 269. TURKEY ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 270. TURKEY ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 271. TURKEY ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 272. TURKEY ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 273. TURKEY ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 274. TURKEY ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 275. UNITED ARAB EMIRATES ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 276. UNITED ARAB EMIRATES ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 277. UNITED ARAB EMIRATES ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 278. UNITED ARAB EMIRATES ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 279. UNITED ARAB EMIRATES ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 280. UNITED ARAB EMIRATES ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 281. UNITED KINGDOM ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 282. UNITED KINGDOM ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 283. UNITED KINGDOM ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 284. UNITED KINGDOM ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 285. UNITED KINGDOM ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 286. UNITED KINGDOM ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 287. ANTIPYRINE MARKET SHARE, BY KEY PLAYER, 2023
TABLE 288. ANTIPYRINE MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Antipyrine market, which are profiled in this report, include:
  • AbbVie
  • Amgen
  • AstraZeneca
  • Bayer
  • Bristol-Myers Squibb
  • Eli Lilly and Company
  • Gilead Sciences
  • GlaxoSmithKline
  • Hoffmann-La Roche
  • Johnson & Johnson
  • Merck & Co.
  • Novartis
  • Novo Nordisk
  • Pfizer
  • Roche
  • Sanofi
  • Shionogi
  • Sun Pharmaceutical
  • Takeda Pharmaceutical Company
  • Teva Pharmaceutical Industries

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages189
PublishedOctober 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 382.99 Million
Forecasted Market Value ( USD ) by 2030 $ 489.29 Million
Compound Annual Growth Rate4.3%
Regions CoveredGlobal
No. of Companies Mentioned21

Related Topics

Related Reports

Antipyrine (CAS 60-80-0) Global Market Research Report 2024 - Product Image

Antipyrine (CAS 60-80-0) Global Market Research Report 2024

  • Report
  • 50 Pages
  • Global
From
Antipyrine salicylate (CAS 520-07-0) Global Market Research Report 2024 - Product Image

Antipyrine salicylate (CAS 520-07-0) Global Market Research Report 2024

  • Report
  • 50 Pages
  • Global
From
Migraine Drugs Market by Therapeutic Class, Treatment Type, Route of Administration, Distribution - Global Forecast 2025-2030 - Product Image

Migraine Drugs Market by Therapeutic Class, Treatment Type, Route of Administration, Distribution - Global Forecast 2025-2030

  • Report
  • 187 Pages
  • Global
From
Migraine Drugs Market Size, Share & Trends Analysis Report By Therapeutic Class (Ditans, NSAIDs), By Route Of Administration (Oral, Injectable), By Treatment, By Age Group, By Availability, By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Migraine Drugs Market Size, Share & Trends Analysis Report By Therapeutic Class (Ditans, NSAIDs), By Route Of Administration (Oral, Injectable), By Treatment, By Age Group, By Availability, By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 159 Pages
  • Global
From
Osteoarthritis Pain Drug Market by Drug Class, Route of Administration, Distribution Channel - Global Forecast 2025-2030 - Product Image

Osteoarthritis Pain Drug Market by Drug Class, Route of Administration, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 195 Pages
  • Global
From

About the Antipyrine Market

Antipyrine is an analgesic drug used to treat mild to moderate pain. It is a non-opioid analgesic, meaning it does not contain any of the active ingredients found in opioids. Antipyrine is often used to treat headaches, muscle aches, and other types of pain. It is also used to reduce fever and inflammation. Antipyrine is available in both oral and topical forms, and is often combined with other analgesics such as aspirin or ibuprofen. Antipyrine is a widely used analgesic, and is available in many countries around the world. It is often used in combination with other analgesics to provide more effective pain relief. It is also used in combination with other medications to treat certain medical conditions. Some of the companies in the Antipyrine market include Pfizer, GlaxoSmithKline, Merck, Novartis, and Johnson & Johnson. These companies produce a variety of Antipyrine products, including tablets, capsules, and topical creams. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.